Advertisement
Advertisement
APUS
Apimeds Pharmaceuticals US, Inc.
4.92
USDSponsored
+2.63
+114.85%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
5.30
+0.38
+7.78%
Apimeds Pharmaceuticals US, Inc. Financial Snapshot
| Market Cap | 8M |
| Beta | 0.06 |
| Earnings Per Share (EPS) | -36.57 |
| Price-to-Book (P/B) Ratio | 0.03 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 13.53% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -59.01% |
| Current Ratio | 0.51% |
| Free Cash Flow | -7.74M |
